Funding
Funding not disclosed
Founders
Product
Problem
Developing effective solutions for health and environmental challenges often requires access to specialized microbial strains and advanced cultivation techniques. Traditional methods for strain acquisition and cultivation can be resource-intensive and may not yield the desired efficacy for targeted applications.
Solution
Coenbio specializes in the acquisition and cultivation of beneficial microbial strains to develop core ingredients for the food and medicine industries. Leveraging proprietary strain acquisition technology and a diverse repository of native beneficial microbes, the company focuses on collaborative research to create innovative solutions. These solutions address key areas such as hair growth promotion, liver and gut health improvement, anti-diabetic and anti-obesity applications, and environmental remediation.
Target Audience
Coenbio serves pharmaceutical companies, nutraceutical manufacturers, cosmetic ingredient suppliers, and environmental technology firms seeking advanced microbial solutions.
Features
- World-class strain acquisition technology for identifying and isolating novel microbial strains.
- Extensive library of native beneficial microbial resources.
- Collaborative research framework to develop targeted microbiome-based solutions.
- Expertise in pure strain isolation and artificial cultivation techniques.
- High-speed and high-concentration cultivation technologies for microbial strains.
- Analysis technology for novel substances produced by beneficial microbes.
- Patented technologies and PCT applications in areas including hair growth, liver/gut health, and anti-diabetic/anti-obesity applications.
- Involvement in national research projects and clinical studies.
- Development of microbial agents for environmental applications, including radioactive waste and contaminated soil remediation.